|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
| PMC |
7571312 |
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therape |
130 KB |
2020-11-19 |
|
18 |
|
3,448 |
-
|
| PMC |
7291971 |
Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guan |
87.7 KB |
2020-10-13 |
|
20 |
|
1,738 |
-
|
| PMC |
7594251 |
NMR as a “Gold Standard” Method in Drug Design and Discovery
Abstract
Studying disease models at th |
130 KB |
2020-11-19 |
|
17 |
|
1,441 |
-
|
| PMC |
7335494 |
Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pat |
99.5 KB |
2020-10-14 |
|
20 |
|
1,416 |
-
|
| PMC |
7352545 |
SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylatio |
87.1 KB |
2020-09-27 |
|
18 |
|
1,401 |
-
|
| PMC |
7461420 |
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective
PILLAIYAR et al.
Abs |
109 KB |
2020-09-27 |
|
16 |
|
1,329 |
-
|
| PMC |
7601109 |
Apitherapy for Age-Related Skeletal Muscle Dysfunction (Sarcopenia): A Review on the Effects of Roya |
105 KB |
2020-11-19 |
|
17 |
|
1,325 |
-
|
| PMC |
7600245 |
Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A |
95.4 KB |
2020-11-19 |
|
17 |
|
1,285 |
-
|
| PMC |
7589163 |
The Role of Micronutrients in Support of the Immune Response against Viral Infections
Abstract
Vira |
98.4 KB |
2020-11-19 |
|
16 |
|
1,256 |
-
|
| PMC |
7279430 |
Essential Oils as Antiviral Agents, Potential of Essential Oils to Treat SARS-CoV-2 Infection: An In |
75.3 KB |
2020-09-27 |
|
18 |
|
1,178 |
-
|
